Skip to main content
. 2020 Jun 22:1–13. doi: 10.1080/07391102.2020.1779818

Table 4.

Pharmacokinetic properties of N3 and green tea polyphenols.

Compound MW H-Ac H-Do Nrot TPSA LogP IA TC LD50 HT AT MTD NLV
N3 684.82 10 5 23 196.88 2.1352 62.162 0.843 4.355 Yes No −0.341 2
Epigallocatechin (EGC) 306.27 7 6 1 130.61 1.2517 54.128 0.328 2.492 No No 0.506 1
Gallocatechin (GC) 306.27 7 6 1 130.61 1.2517 54.128 0.328 2.492 No No 0.506 1
Catechin (C) 290.27 6 5 1 110.38 1.5461 68.829 0.183 2.428 No No 0.438 0
Epicatechin (EC) 290.27 6 5 1 110.38 1.5461 68.829 0.183 2.428 No No 0.438 0
Catechin gallate (CG) 442.37 10 7 4 177.14 2.5276 62.096 −0.169 2.558 No No 0.449 1
Epigallocatechin gallate (EGCG) 458.37 11 8 4 197.37 2.2332 47.395 0.292 2.522 No No 0.441 2
Epicatechin gallate (ECG) 442.37 10 7 4 177.14 2.5276 62.096 −0.169 2.558 No No 0.449 1
Gallocatechin-3-gallate (GCG) 458.37 11 8 4 197.37 2.2332 47.395 0.292 2.522 No No 0.441 2

MW, molecular weight (g/mol); H-Ac, no. of hydrogen bond acceptor; H-Do, no. of hydrogen bond donors; Nrot, no. of rotatable bonds; TPSA, topological polar surface area (Å2); LogP, predicted octanol/water partition coefficient; IA, intestinal absorption (% absorbed); TC, total clearance (log ml/min/kg); LD50, oral rat acute toxicity; HT, hepatotoxicity; AT, AMES toxicity; MTD, maximum tolerated dose for human (log mg/kg/day); NLV, no. of Lipinski rule violation.